cell-based vaccine (University of Pittsburgh)

N/A

Report date: 2026/01/22 16:42:18

Base Information

Drug Namecell-based vaccine (University of Pittsburgh)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccineVaccines > Application > Therapeutic vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Pittsburgh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Pittsburgh

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A